$KNW
KNOW LABS, INC.

2023 Q3 Form 10-Q Financial Statement

#000165495423010781 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $789.1K $1.360M
YoY Change -14.42%
% of Gross Profit
Research & Development $1.541M $1.880M
YoY Change 47.7%
% of Gross Profit
Depreciation & Amortization $53.48K $54.45K
YoY Change -45.88%
% of Gross Profit
Operating Expenses $2.330M $3.239M
YoY Change 7.07%
Operating Profit -$3.239M
YoY Change 7.07%
Interest Expense $12.82K $23.51K
YoY Change -90.19%
% of Operating Profit
Other Income/Expense, Net -$364.6K -$360.6K
YoY Change -1726.86%
Pretax Income -$2.936M -$3.600M
YoY Change 19.87%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.125M -$3.600M
YoY Change 19.87%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.06 -$0.18
COMMON SHARES
Basic Shares Outstanding 52.36M shares 48.49M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.024M $3.929M
YoY Change -52.96%
Cash & Equivalents $8.024M $3.929M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $8.024M $3.929M
YoY Change -36.29% -53.22%
LONG-TERM ASSETS
Property, Plant & Equipment $81.33K $300.1K
YoY Change -90.58% -68.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.77K $15.77K
YoY Change 14.52%
Total Long-Term Assets $242.2K $507.6K
YoY Change -79.21% -58.71%
TOTAL ASSETS
Total Short-Term Assets $8.024M $3.929M
Total Long-Term Assets $242.2K $507.6K
Total Assets $8.266M $4.436M
YoY Change -39.92% -53.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.293M $526.7K
YoY Change 29.91%
Accrued Expenses $94.06K $416.2K
YoY Change -79.68% -22.06%
Deferred Revenue
YoY Change
Short-Term Debt $2.762M $2.255M
YoY Change 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.522M $3.721M
YoY Change 18.73% -19.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.522M $3.721M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $4.522M $3.721M
YoY Change 16.07% -20.97%
SHAREHOLDERS EQUITY
Retained Earnings -$121.8M -$118.7M
YoY Change 20.16% 23.89%
Common Stock $80.36K $52.36K
YoY Change 66.86% 19.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.744M $715.4K
YoY Change
Total Liabilities & Shareholders Equity $8.266M $4.436M
YoY Change -39.92% -53.92%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$3.125M -$3.600M
YoY Change 19.87%
Depreciation, Depletion And Amortization $53.48K $54.45K
YoY Change -45.88%
Cash From Operating Activities -$1.378M -$2.635M
YoY Change -1.27%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $38.94K
YoY Change -334.58%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$38.94K
YoY Change 134.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.473M 377.2K
YoY Change -352.7%
NET CHANGE
Cash From Operating Activities -1.378M -2.635M
Cash From Investing Activities 0.000 -38.94K
Cash From Financing Activities 5.473M 377.2K
Net Change In Cash 4.095M -2.297M
YoY Change -18.98%
FREE CASH FLOW
Cash From Operating Activities -$1.378M -$2.635M
Capital Expenditures $0.00 $38.94K
Free Cash Flow -$1.378M -$2.674M
YoY Change 0.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4253997 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52358463 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48156062 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001074828
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52358463 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48156062 shares
CY2021Q3 knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbers
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbers
22564255 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2021Q3 knwn Outstanding At Begenning Of Period
OutstandingAtBegenningOfPeriod
0.998
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
knwn Provision For Income Taxes
ProvisionForIncomeTaxes
0 usd
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0 pure
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0 pure
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Entity File Number
EntityFileNumber
000-30262
dei Entity Registrant Name
EntityRegistrantName
KNOW LABS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0273142
dei Entity Address Address Line1
EntityAddressAddressLine1
500 Union Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 810
dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Country
EntityAddressCountry
US
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98101
dei City Area Code
CityAreaCode
206
dei Local Phone Number
LocalPhoneNumber
903-1351
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
KNW
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52358463 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3928865 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12593692 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
3928865 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
12593692 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
300097 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
862977 usd
CY2023Q2 us-gaap Other Assets
OtherAssets
15766 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
13767 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
191769 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
287930 usd
CY2023Q2 us-gaap Assets
Assets
4436497 usd
CY2022Q3 us-gaap Assets
Assets
13758366 usd
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
526688 usd
CY2022Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
526968 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
416191 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
462940 usd
CY2023Q2 knwn Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
320427 usd
CY2022Q3 knwn Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
348264 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2255066 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2255066 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
202712 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
215397 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3721084 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3808635 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87118 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
87118 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
52358 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
48158 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119375700 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
111209388 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118715450 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101397738 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
715413 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9862613 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4436497 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13758366 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
4360087 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1879519 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1272537 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6186039 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3406996 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1359782 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1588823 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5507511 usd
CY2023Q2 us-gaap Selling Expense
SellingExpense
0 usd
CY2022Q2 us-gaap Selling Expense
SellingExpense
164093 usd
us-gaap Selling Expense
SellingExpense
0 usd
us-gaap Selling Expense
SellingExpense
3436955 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3239301 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
3025453 usd
us-gaap Operating Expenses
OperatingExpenses
11693550 usd
us-gaap Operating Expenses
OperatingExpenses
11097948 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3239301 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3025453 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11693550 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6737861 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
23511 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
239760 usd
us-gaap Interest Expense
InterestExpense
275301 usd
us-gaap Interest Expense
InterestExpense
8024709 usd
CY2023Q2 us-gaap Other Income
OtherIncome
-384137 usd
CY2022Q2 us-gaap Other Income
OtherIncome
261927 usd
us-gaap Other Income
OtherIncome
-384137 usd
us-gaap Other Income
OtherIncome
261927 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-360626 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22167 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-659438 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7762782 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3599927 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3003286 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12352988 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14500643 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3599927 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3003286 usd
us-gaap Net Income Loss
NetIncomeLoss
-12352988 usd
us-gaap Net Income Loss
NetIncomeLoss
-14500643 usd
CY2023Q2 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
1627230 usd
CY2022Q2 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
0 usd
us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
1627230 usd
us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
0 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3337494 usd
CY2022Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
3337494 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8564651 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3003286 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17317712 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-14500643 usd
CY2023Q2 knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.18
CY2022Q2 knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.07
knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.36
knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.37
CY2023Q2 knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
48928911 shares
CY2022Q2 knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
43760904 shares
knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
48604274 shares
knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
39032860 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1242163 usd
CY2021Q4 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
204170 usd
CY2021Q4 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
766486 usd
CY2021Q4 knwn Issuance Of Common Stock For Stock Option Exercises Amount
IssuanceOfCommonStockForStockOptionExercisesAmount
2344 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-5356619 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3141456 usd
CY2022Q1 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
432481 usd
CY2022Q1 knwn Conversion Of Debt Offering And Accrued Interest Note7 Amount
ConversionOfDebtOfferingAndAccruedInterestNote7Amount
15345720 usd
CY2022Q1 knwn Issuance Of Common Stock For Stock Option Exercises Amount
IssuanceOfCommonStockForStockOptionExercisesAmount
9000 usd
CY2022Q1 knwn Issuance Of Common Stock For Services Amount
IssuanceOfCommonStockForServicesAmount
153000 usd
CY2022Q1 knwn Issuance Of Warrant For Services
IssuanceOfWarrantForServices
71220 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6140738 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
6729227 usd
CY2022Q2 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
919224 usd
CY2022Q2 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
27500 usd
CY2022Q2 knwn Issuance Of Common Stock For Stock Option Exercises Amount
IssuanceOfCommonStockForStockOptionExercisesAmount
2343 usd
CY2022Q2 knwn Modification Of Warrant Interest Expense
ModificationOfWarrantInterestExpense
244260 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3003286 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4919268 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9862613 usd
CY2022Q4 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
744640 usd
CY2022Q4 knwn Issuance Of Common Stock For Stock Option Exercises Amount
IssuanceOfCommonStockForStockOptionExercisesAmount
2343 usd
CY2022Q4 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
12500 usd
CY2022Q4 knwn Expenses For Extension Of Notes And Warrants
ExpensesForExtensionOfNotesAndWarrants
206994 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-3822859 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7006231 usd
CY2023Q1 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
1182547 usd
CY2023Q1 knwn Expenses For Extension Of Notes And Warrants
ExpensesForExtensionOfNotesAndWarrants
142727 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4930202 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3401303 usd
CY2023Q2 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
536858 usd
CY2023Q2 knwn Issuance Of Common Stock For Stock Option Exercises Amount
IssuanceOfCommonStockForStockOptionExercisesAmount
2344 usd
CY2023Q2 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
374835 usd
CY2023Q2 knwn Common Stock Dividends On Series D Preferred Stock Amount
CommonStockDividendsOnSeriesDPreferredStockAmount
0 usd
CY2023Q2 knwn Deemed Dividends On Series C And D Preferred Stock
DeemedDividendsOnSeriesCAndDPreferredStock
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3599927 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
715413 usd
us-gaap Profit Loss
ProfitLoss
-12352988 usd
us-gaap Profit Loss
ProfitLoss
-14500643 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
259541 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
218683 usd
knwn Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
0 usd
knwn Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
153000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
71220 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
384137 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Interest Expense Foreign Deposits
InterestExpenseForeignDeposits
349721 usd
us-gaap Interest Expense Foreign Deposits
InterestExpenseForeignDeposits
244260 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
2464045 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1555875 usd
knwn Right Of Use Net
RightOfUseNet
-3642 usd
knwn Right Of Use Net
RightOfUseNet
-20705 usd
knwn Gain On Forgiveness Of Notes Payable Ppp Loans
GainOnForgivenessOfNotesPayablePppLoans
0 usd
knwn Gain On Forgiveness Of Notes Payable Ppp Loans
GainOnForgivenessOfNotesPayablePppLoans
-252700 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7272911 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1999 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
0 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-46146 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-74866 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1612959 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8976051 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3691286 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
80798 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
843557 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80798 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-843557 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
179103 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4687 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13687 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
387335 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
793986 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
392022 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
628570 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8664827 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3906273 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12593692 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12258218 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3928865 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8351945 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
14209000 usd
knwn Conversion Of Accrued Interest
ConversionOfAccruedInterest
0 usd
knwn Conversion Of Accrued Interest
ConversionOfAccruedInterest
1136720 usd
us-gaap Dividends Common Stock
DividendsCommonStock
1627230 usd
us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
3337494 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2023Q2 knwn Authorized Shares Of Capital Common Stock
AuthorizedSharesOfCapitalCommonStock
200000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 knwn Authorized Common Stock Increased
AuthorizedCommonStockIncreased
200000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 knwn Cash And Cash Equivalents
CashAndCashEquivalents
3928865 usd
CY2023Q2 knwn Net Working Capital
NetWorkingCapital
715213 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2970479 usd
knwn Net Proceed From Deducting Issue Stock
NetProceedFromDeductingIssueStock
15682308 usd
CY2023Q2 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000 usd
us-gaap Revenue Recognition Leases
RevenueRecognitionLeases
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Revenue Recognition</em></strong><strong> </strong>– The Company determines revenue recognition from contracts with customers through the following steps:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the contract, or contracts, with the customer;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the performance obligations in the contract;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">determination of the transaction price;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">allocation of the transaction price to the performance obligations in the contract; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">recognition of the revenue when, or as, the Company satisfies a performance obligation.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. During the three months ended December 31, 2021, the Company generated revenue from digital asset sales of NFTs. The Company engineering team, using its research data, AI and proprietary algorithms, produced NFTs in the form of digital art. The NFTs produced had no recorded cost basis. The Company does not expect future activity or revenue from that source.</p>
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6186039 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3406996 usd
knwn Severance And Other Expenses
SeveranceAndOtherExpenses
859000 usd
us-gaap Advertising Expense
AdvertisingExpense
149297 usd
us-gaap Advertising Expense
AdvertisingExpense
514401 usd
CY2023Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
3678865 usd
CY2022Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
11821931 usd
us-gaap Derivatives Methods Of Accounting Hedge Effectiveness
DerivativesMethodsOfAccountingHedgeEffectiveness
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Derivative Financial Instruments</em></strong><strong> – </strong>Pursuant to ASC 815 “Derivatives and Hedging”, the Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company then determines if an embedded derivative must be bifurcated and separately accounted for. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined that the conversion features for purposes of bifurcation within its currently outstanding convertible notes payable were immaterial and there was no derivative liability to be recorded as of June 30, 2023 and September 30, 2022.</p>
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52358463 shares
CY2023Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
14506158 shares
CY2023Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
2255066 shares
knwn Convertible Debentures
ConvertibleDebentures
2255066 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Use of Estimates</em></strong> – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
961529 usd
CY2022Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1510265 usd
CY2023Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
26855 usd
CY2022Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
26855 usd
CY2023Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3612 usd
CY2022Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3612 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
691899 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
677755 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
300097 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
862977 usd
us-gaap Depreciation
Depreciation
259541 usd
us-gaap Depreciation
Depreciation
218683 usd
CY2023Q2 knwn Assets Net Book Value
AssetsNetBookValue
384137 usd
CY2023Q2 knwn Total Lease Liability
TotalLeaseLiability
163000 usd
CY2022Q3 knwn Total Lease Liability
TotalLeaseLiability
302000 usd
CY2023Q2 knwn Right Of Use Assets
RightOfUseAssets
156000 usd
CY2022Q3 knwn Right Of Use Assets
RightOfUseAssets
288000 usd
us-gaap Lease Cost
LeaseCost
203000 usd
us-gaap Lease Cost
LeaseCost
131000 usd
knwn Weighted Average Remaining Lease Term
WeightedAverageRemainingLeaseTerm
P12M
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07 pure
CY2023Q2 knwn Total Remaining Payments
TotalRemainingPayments
204534 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1822 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
202712 usd
CY2023Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
92171 usd
CY2022Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
86562 usd
us-gaap Equipment Expense
EquipmentExpense
155702 usd
CY2022 knwn Amortization Of Debt Discount Premiums
AmortizationOfDebtDiscountPremiums
7272911 usd
CY2023Q2 knwn Convertible Notes Conversions
ConvertibleNotesConversions
0 usd
CY2022Q3 knwn Convertible Notes Conversions
ConvertibleNotesConversions
-14209000 usd
CY2023Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
2255066 usd
CY2022Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
2255066 usd
us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
7684381 shares
CY2023Q2 us-gaap Share Price
SharePrice
0.25
knwn Received Of Warrant
ReceivedOfWarrant
387335 usd
us-gaap Interest Expense Other
InterestExpenseOther
194019 usd
CY2023Q2 knwn Warrant Issued To Common Stock
WarrantIssuedToCommonStock
2632727 shares
CY2022Q3 knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbers
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbers
21786313 shares
CY2022Q3 knwn Outstanding At Begenning Of Period
OutstandingAtBegenningOfPeriod
1.029
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2632727 shares
knwn Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Prices
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrices
-0.250
knwn Stock Issued During Period Shares Warrants Forfieted
StockIssuedDuringPeriodSharesWarrantsForfieted
297273 shares
knwn Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInWeightedAverageExercisePrice
-0.250
knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbe
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbe
18856313 shares
CY2023Q2 knwn Outstanding At End Of Period
OutstandingAtEndOfPeriod
1.150
CY2023Q2 knwn Exercisable At End Of Period
ExercisableAtEndOfPeriod
18856313 shares
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
18856313 shares
knwn Weighted Averages Remaining Life Years
WeightedAveragesRemainingLifeYears
P2Y3M7D
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
1.150
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
18856313 shares
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.150
srt Federal Funds Sold Average Yield
FederalFundsSoldAverageYield
0 pure
knwn Finite Lived Intangible Asset Expected Minimum Useful Life
FiniteLivedIntangibleAssetExpectedMinimumUsefulLife
P3Y
knwn Finite Lived Intangible Asset Expected Maximum Useful Life
FiniteLivedIntangibleAssetExpectedMaximumUsefulLife
P5Y
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
1.04 pure
us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.0296 pure
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
18856313 usd
knwn Sharebased Compensation Arrangements By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementsBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
6569868 usd
knwn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Unearned
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUnearned
4158333 shares
CY2023Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.381
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10277655 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.647
knwn Stock Issued During Period Shares Stock Option Exercised
StockIssuedDuringPeriodSharesStockOptionExercised
166890 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.272
knwn Stock Option Grants
StockOptionGrants
14506158 shares
knwn Intrinsic Value
IntrinsicValue
364605 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2464045 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1555875 usd
CY2023Q2 knwn Unrecognized Compensation Costs
UnrecognizedCompensationCosts
5454046 usd
knwn Provision For Income Taxes
ProvisionForIncomeTaxes
0 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.000 pure
CY2017Q2 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
3334 usd
us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
2986 usd
CY2023Q2 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
2908 usd
CY2021Q2 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
8697 usd
CY2021Q2 knwn Lease Description
LeaseDescription
increases by 3% annually. The lease expires on June 30, 2024. The lease can be extended for one additional three-year term
CY2021Q4 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
5000 usd
CY2022Q3 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
7000 usd
CY2022Q3 us-gaap Payments For Rent
PaymentsForRent
91500 usd
us-gaap Payments For Rent
PaymentsForRent
28000 usd
CY2022Q4 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
2250 usd
CY2023Q2 knwn Segment Revenues
SegmentRevenues
0 usd
CY2023Q2 knwn Segment Net Income Loss
SegmentNetIncomeLoss
3239000 usd
CY2022Q2 knwn Segment Revenues
SegmentRevenues
0 usd
CY2022Q2 knwn Segment Net Income Loss
SegmentNetIncomeLoss
-3025000 usd
CY2022Q2 knwn Segment Asset
SegmentAsset
9627000 usd
CY2023Q2 knwn Segment Asset
SegmentAsset
4436000 usd
knwn Segment Revenues
SegmentRevenues
0 usd
knwn Segment Net Income Loss
SegmentNetIncomeLoss
-11694000 usd
knwn Segment Asset
SegmentAsset
4436000 usd
knwn Segment Revenues
SegmentRevenues
4360 usd
knwn Segment Net Income Loss
SegmentNetIncomeLoss
-6739000 usd
knwn Segment Asset
SegmentAsset
9627000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
3453802 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
9242544 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
knwn-20230630_cal.xml Edgar Link unprocessable
0001654954-23-010781-index-headers.html Edgar Link pending
0001654954-23-010781-index.html Edgar Link pending
0001654954-23-010781.txt Edgar Link pending
0001654954-23-010781-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
knwn-20230630.xsd Edgar Link pending
knwn_10q.htm Edgar Link pending
knwn_10qimg18.jpg Edgar Link pending
knwn_ex311.htm Edgar Link pending
knwn_ex312.htm Edgar Link pending
knwn_ex321.htm Edgar Link pending
knwn_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
knwn-20230630_def.xml Edgar Link unprocessable
knwn-20230630_lab.xml Edgar Link unprocessable
knwn-20230630_pre.xml Edgar Link unprocessable
knwn_10q_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending